Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
6.84
-0.34 (-4.74%)
Oct 19, 2026, 10:41 AM EDT - Market open
CPIX Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 102 | 60 | 33 | 27 | 33 | 69 | |
Market Cap Growth | 99.00% | 78.87% | 24.62% | -17.94% | -52.77% | 55.54% |
Enterprise Value | 103 | 54 | 37 | 27 | 31 | 59 |
Last Close Price | 7.18 | 3.09 | 1.84 | 1.39 | 1.74 | 3.62 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
PS Ratio | 2.43 | 1.34 | 0.88 | 0.68 | 0.78 | 1.92 |
PB Ratio | 6.17 | 2.42 | 1.48 | 0.91 | 0.91 | 1.62 |
P/TBV Ratio | 6.18 | 5.99 | 8.39 | 4.39 | 6.84 | 3.83 |
P/FCF Ratio | 157.30 | 12.31 | - | 4.59 | 3.90 | 11.04 |
P/OCF Ratio | 144.21 | 12.07 | - | 4.38 | 3.85 | 10.86 |
PEG Ratio | - | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.45 | 1.22 | 0.98 | 0.67 | 0.73 | 1.65 |
EV/EBITDA Ratio | 98.87 | 40.09 | - | - | - | - |
EV/FCF Ratio | 158.55 | 11.22 | - | 4.56 | 3.67 | 9.49 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.28 | 0.42 | 0.91 | 0.63 | 0.58 | 0.38 |
Debt / EBITDA Ratio | 1.42 | 2.83 | 50.39 | 32.10 | 15.97 | - |
Debt / FCF Ratio | 6.89 | 2.11 | - | 3.17 | 2.51 | 2.57 |
Net Debt / Equity Ratio | 0.05 | -0.05 | 0.12 | 0.00 | 0.03 | -0.26 |
Net Debt / EBITDA Ratio | 0.78 | -0.93 | -1.70 | -0.08 | -3.19 | 3.58 |
Net Debt / FCF Ratio | 1.25 | -0.26 | -3.84 | 0.02 | 0.14 | -1.76 |
Asset Turnover | 0.68 | 0.58 | 0.48 | 0.45 | 0.47 | 0.40 |
Inventory Turnover | 4.10 | 1.30 | 1.53 | 0.84 | 1.00 | 0.92 |
Quick Ratio | 0.49 | 0.77 | 0.94 | 1.00 | 1.15 | 1.76 |
Current Ratio | 0.96 | 1.01 | 1.15 | 1.28 | 1.61 | 2.37 |
Return on Equity (ROE) | -14.39% | -12.17% | -24.88% | -19.41% | -14.38% | -12.51% |
Return on Assets (ROA) | -2.91% | -2.29% | -5.11% | -4.44% | -4.02% | -5.30% |
Return on Invested Capital (ROIC) | -15.88% | -11.53% | -23.60% | -18.67% | -16.59% | -21.68% |
Return on Capital Employed (ROCE) | -11.00% | -7.00% | -14.60% | -11.50% | -8.90% | -11.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -10.15% | -4.76% | -19.47% | -23.51% | -17.12% | -5.09% |
FCF Yield | 0.64% | 8.12% | -2.04% | 21.77% | 25.66% | 9.05% |
Buyback Yield / Dilution | -2.64% | -5.65% | 1.67% | 1.82% | 2.29% | 1.70% |